Nationwide Children's Research News

Oct 09, 2023

Study Finds GERD Less Likely Cause of Fussiness in Irritable Infants

In a new study published in The Journal of Pediatrics, researchers in the Abigail Wexner Research Institute at Nationwide Children’s Hospital have found that high-risk infants who express irritability and arching of their backs likely are not suffering from gastroesophageal reflux disease (GERD).

Sep 18, 2023

Study Shows Nearly 300% Increase in ADHD Medication Errors

In a new study, published today in Pediatrics, researchers at the Center for Injury Research and Policy and Central Ohio Poison Center at Nationwide Children’s Hospital investigated the characteristics and trends of out-of-hospital ADHD medication errors among people younger than 20 years old reported to U.S. poison centers from 2000 through 2021.

Sep 13, 2023

Nationwide Children’s, Ohio State Receive $17.7 Million to Study Children’s Health

A research team at Nationwide Children’s Hospital and The Ohio State University Wexner Medical Center was recently awarded $17.7 million from the National Institutes of Health (NIH) to join a national consortium to study how childhood environments and experiences influence the health of children as they grow and develop.

Sep 11, 2023

$6.95 Million FDA Grant to Help Create Medical Devices Just for Children

The Food and Drug Administration (FDA) announced a $6.95 million grant to be distributed over five years to create a new consortium led by investigators from Nationwide Children’s Hospital, The Ohio State University, Cleveland Clinic Children’s, and Cincinnati Children’s to help increase the number of pediatric medical devices across the nation.

From Bench to Bedside: Patient with Duchenne Muscular Dystrophy Receives First Dose of Gene Therapy Developed at Nationwide Children’s Hospital
Aug 08, 2023

From Bench to Bedside: Patient with Duchenne Muscular Dystrophy Receives First Dose of Gene Therapy Developed at Nationwide Children’s Hospital

In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children’s, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently approved gene therapy for Duchenne muscular dystrophy at Nationwide Children’s Hospital, where the therapy was invented and initially tested.

Jun 22, 2023

FDA Approves First Gene Therapy Treatment for Duchenne Muscular Dystrophy Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital

Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its accelerated approval of SRP-9001/ELEVIDYS for Duchenne muscular dystrophy (DMD) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.

Jun 13, 2023

Mapping the 3D Structure of Rhabdomyosarcoma Chromatin

In a paper published in Nucleic Acids Research Cancer (NAR Cancer), researchers from the Center for Childhood Cancer Research at Nationwide Children’s and their collaborators report a comprehensive 3D chromatin structural analysis and characterization of rhabdomyosarcoma (RMS).

Nationwide Children's Hospital Names First Chief Data Sciences Officer
Apr 25, 2023

Nationwide Children's Hospital Names First Chief Data Sciences Officer

Peter White, PhD, has been named the inaugural Chief Data Sciences Officer (CDSO) of the Abigail Wexner Research Institute (AWRI) at Nationwide Children's Hospital. The CDSO will lead biomedical data science initiatives to support Nationwide Children's mission as a leader in pediatric health care innovation.

Using Machine Learning in the Electronic Medical Record to Save Lives
Apr 06, 2023

Using Machine Learning in the Electronic Medical Record to Save Lives

In a report published in Pediatric Critical Care Medicine, a team from Nationwide Children's Hospital describes a machine learning tool for timely identification of hospitalized children at risk for deterioration – a worsening clinical condition with increased risk of morbidity and mortality. The tool, which is trained on disease-specific groups, promisingly outperformed the existing situational awareness program in identifying at-risk children.

Feb 27, 2023

Dr. Patrick Gallagher of Yale University Named Director of Perinatal Research Center at Nationwide Children's Hospital

Patrick Gallagher, MD, from Yale University has been named the new director of the Center for Perinatal Research in the Abigail Wexner Research Institute at Nationwide Children's Hospital.